113 related articles for article (PubMed ID: 26536783)
1. [A Novel Clinical Entity "Anti-PIT-1 Antibody Syndrome"--Autoimmunity against a Transcription Factor].
Takahashi Y; Bando H; Iguchi G
Rinsho Byori; 2015 Apr; 63(4):491-7. PubMed ID: 26536783
[TBL] [Abstract][Full Text] [Related]
2. Anti-PIT-1 antibody syndrome; a novel clinical entity leading to hypopituitarism.
Bando H; Iguchi G; Yamamoto M; Hidaka-Takeno R; Takahashi Y
Pediatr Endocrinol Rev; 2015 Mar; 12(3):290-6. PubMed ID: 25962206
[TBL] [Abstract][Full Text] [Related]
3. A Novel Clinical Entity of Autoimmune Endocrinopathy: Anti-PIT-1 Antibody Syndrome.
Iguchi G; Bando H; Takahashi Y
Front Horm Res; 2017; 48():76-83. PubMed ID: 28245453
[TBL] [Abstract][Full Text] [Related]
4. Involvement of PIT-1-reactive cytotoxic T lymphocytes in anti-PIT-1 antibody syndrome.
Bando H; Iguchi G; Fukuoka H; Yamamoto M; Hidaka-Takeno R; Okimura Y; Matsumoto R; Suda K; Nishizawa H; Takahashi M; Tojo K; Takahashi Y
J Clin Endocrinol Metab; 2014 Sep; 99(9):E1744-9. PubMed ID: 24937538
[TBL] [Abstract][Full Text] [Related]
5. Adult combined GH, prolactin, and TSH deficiency associated with circulating PIT-1 antibody in humans.
Yamamoto M; Iguchi G; Takeno R; Okimura Y; Sano T; Takahashi M; Nishizawa H; Handayaningshi AE; Fukuoka H; Tobita M; Saitoh T; Tojo K; Mokubo A; Morinobu A; Iida K; Kaji H; Seino S; Chihara K; Takahashi Y
J Clin Invest; 2011 Jan; 121(1):113-9. PubMed ID: 21123951
[TBL] [Abstract][Full Text] [Related]
6. A novel thymoma-associated autoimmune disease: Anti-PIT-1 antibody syndrome.
Bando H; Iguchi G; Okimura Y; Odake Y; Yoshida K; Matsumoto R; Suda K; Nishizawa H; Fukuoka H; Mokubo A; Tojo K; Maniwa Y; Ogawa W; Takahashi Y
Sci Rep; 2017 Feb; 7():43060. PubMed ID: 28216655
[TBL] [Abstract][Full Text] [Related]
7. A missense single-nucleotide polymorphism in the sialic acid acetylesterase (SIAE) gene is associated with anti-PIT-1 antibody syndrome.
Yamamoto M; Iguchi G; Bando H; Fukuoka H; Suda K; Takahashi M; Nishizawa H; Matsumoto R; Tojo K; Mokubo A; Ogata T; Takahashi Y
Endocr J; 2014; 61(6):641-4. PubMed ID: 24748456
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune Pituitary Disease: New Concepts With Clinical Implications.
Yamamoto M; Iguchi G; Bando H; Kanie K; Hidaka-Takeno R; Fukuoka H; Takahashi Y
Endocr Rev; 2020 Apr; 41(2):. PubMed ID: 31513261
[TBL] [Abstract][Full Text] [Related]
9. Clinical features of anti-pituitary-specific transcription factor-1 (PIT-1) hypophysitis: a new aspect of paraneoplastic autoimmune condition.
Urai S; Iguchi G; Kanie K; Bando H; Yamamoto M; Oi Y; Kashitani Y; Iida K; Kanzawa M; Fukuoka H; Takahashi M; Shintani Y; Ogawa W; Takahashi Y
Eur J Endocrinol; 2024 Jan; 190(1):K1-K7. PubMed ID: 38146732
[TBL] [Abstract][Full Text] [Related]
10. Induction of GH, PRL, and TSH beta mRNA by transfection of Pit-1 in a human pituitary adenoma-derived cell line.
Miyai S; Yoshimura S; Iwasaki Y; Takekoshi S; Lloyd RV; Osamura RY
Cell Tissue Res; 2005 Nov; 322(2):269-77. PubMed ID: 16133148
[TBL] [Abstract][Full Text] [Related]
11. Two Cases of anti-PIT-1 Hypophysitis Exhibited as a Form of Paraneoplastic Syndrome not Associated With Thymoma.
Kanie K; Iguchi G; Inuzuka M; Sakaki K; Bando H; Urai S; Shichi H; Fujita Y; Matsumoto R; Suda K; Yamamoto M; Fukuoka H; Taniguchi T; Ogawa W; Takahashi Y
J Endocr Soc; 2021 Mar; 5(3):bvaa194. PubMed ID: 33506159
[TBL] [Abstract][Full Text] [Related]
12. The early-stage clinical course of anti-pituitary-specific transcription factor-1 hypophysitis diagnosed post-immune checkpoint inhibitor treatment: A case with review of literature.
Urai S; Tomofuji S; Bando H; Kanzawa M; Yamamoto M; Fukuoka H; Tsuda M; Iguchi G; Ogawa W
J Neuroendocrinol; 2024 Jun; 36(6):e13395. PubMed ID: 38631695
[TBL] [Abstract][Full Text] [Related]
13. Combined pituitary hormone deficiency due to the F135C human Pit-1 (pituitary-specific factor 1) gene mutation: functional and structural correlates.
Vallette-Kasic S; Pellegrini-Bouiller I; Sampieri F; Gunz G; Diaz A; Radovick S; Enjalbert A; Brue T
Mol Endocrinol; 2001 Mar; 15(3):411-20. PubMed ID: 11222742
[TBL] [Abstract][Full Text] [Related]
14. A "hot spot" in the Pit-1 gene responsible for combined pituitary hormone deficiency: clinical and molecular correlates.
Cohen LE; Wondisford FE; Salvatoni A; Maghnie M; Brucker-Davis F; Weintraub BD; Radovick S
J Clin Endocrinol Metab; 1995 Feb; 80(2):679-84. PubMed ID: 7852536
[TBL] [Abstract][Full Text] [Related]
15. Novel neuronal and endocrine autoantibody targets in Autoimmune Polyendocrine Syndrome type 1.
Cocco C; Meloni A; Mariotti S; Cossu E; D'amato F; Zulian S; Tongiorgi E; Ferri GL
Autoimmunity; 2012 Sep; 45(6):485-94. PubMed ID: 22506635
[TBL] [Abstract][Full Text] [Related]
16. The turkey transcription factor Pit-1/GHF-1 can activate the turkey prolactin and growth hormone gene promoters in vitro but is not detectable in lactotrophs in vivo.
Weatherly KL; Ramesh R; Strange H; Waite KL; Storrie B; Proudman JA; Wong EA
Gen Comp Endocrinol; 2001 Sep; 123(3):244-53. PubMed ID: 11589626
[TBL] [Abstract][Full Text] [Related]
17. GH and TSH deficiency.
Pfäffle RW; Martinez R; Kim C; Frisch H; Lebl J; Otten B; Heimann G
Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 4():1-5. PubMed ID: 9439906
[TBL] [Abstract][Full Text] [Related]
18. [Progress on pituitary-specific transcription factor (POU1F1) in poultry].
Jiang RS; Yang N
Yi Chuan; 2004 Nov; 26(6):957-61. PubMed ID: 15640133
[TBL] [Abstract][Full Text] [Related]
19. Effects of salmon GnRH and sex steroid hormones on expression of genes encoding growth hormone/prolactin/somatolactin family hormones and a pituitary-specific transcription factor in masu salmon pituitary cells in vitro.
Onuma T; Ando H; Koide N; Okada H; Urano A
Gen Comp Endocrinol; 2005 Sep; 143(2):129-41. PubMed ID: 16061071
[TBL] [Abstract][Full Text] [Related]
20. GH transcription factors.
Pfaffle RW; Kim C; Blankenstein O; Kentrup H
J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():311-7. PubMed ID: 10698595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
